![]() | |
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C16H11ClF2N2O |
Molar mass | 320.72 g·mol−1 |
3D model (JSmol) | |
| |
|
Difludiazepam[1] (Ro07-4065) is abenzodiazepine derivative which is the 2',6'-difluoro derivative offludiazepam. It was invented in the 1970s but was never marketed, and has been used as a research tool to help determine the shape and function of theGABAA receptors, at which it has an IC50 of 4.1nM.[2][3][4] Difludiazepam has subsequently been sold as adesigner drug, and was first notified to theEMCDDA by Swedish authorities in 2017.[5][6]